|
⚲
|
| Keyboard |
| James Peyer | |
|---|---|
| Firm | |
| Address | 228 Park Ave S Suite 66643 New York, NY 10003 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cambrian BioPharma Inc | 021-590950 | Executive Officer | 123.8 M of 129.8 M |
||
| Rapalogix Health Inc | 021-588703 | Director | 19.1 M of 25.0 M |
||
| Rapalogix Health Inc | 021-502595 | Director | 9.1 M of 13.5 M |
||
| Cambrian Biopharma Inc | 021-500632 | Executive Officer | 23.0 M of 37.6 M |
||
| VITA Therapeutics Inc | 021-462316 | Director | 30.9 M of 30.9 M |
||
| Cambrian Biopharma Inc | 021-423260 | Executive Officer | 92.2 M of 100.8 M |
||
| VITA Therapeutics Inc | 021-422876 | Director | 12.0 M of 12.0 M |
||
| Cambrian Biopharma Inc | 021-398458 | Executive Officer | 28.4 M of 28.4 M |
||
| Telos Biotech Inc | 021-370723 | Executive Officer | 0.7 M of 0.7 M |
||
| Isterian Biotech Inc | 021-366456 | Executive Officer | 3.0 M of 3.0 M |
||
| Cambrian Biopharma Inc | 021-359008 | Executive Officer | 4.8 M of 4.8 M |
||
| Delos Pharmaceuticals Inc | 021-289574 | Director | 0.8 M of 3.8 M |
||